Discover
Stocks
Consumer Goods
RIGL
RIGL
Rigel Pharmaceuticals Inc
1.07
-0.02
(
-1.83%
)
Market Open
Delayed Prices By NASDAQ,
in USD
Trade
Buy
RIGL
Rigel Pharmaceuticals Inc
Overview
Chart
Analysis
News
Stats
Trade
Buy
FINANCIAL SUMMARY
For the fiscal year ended 31/12/2022: Rigel Pharmaceuticals Inc's revenues decreased by 19.43% and amounted to 120.24M. Net income decreased by 226.97% to -58.57M. Net assets decreased by 144.83% to -13.62M and EPS decreased from -0.11 to -0.34.
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment